Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
The current Amgen(AMGN) stock price is $430.31, with a market capitalization of 233.77B. The stock trades at a price-to-earnings (P/E) ratio of 26.86 and offers a dividend yield of 2.27%.
On 2026-08-29, Amgen(AMGN) stock traded between a low of $430.06 and a high of $439.70. Shares are currently priced at $430.31, which is +0.1% above the low and -2.1% below the high.
The Amgen(AMGN)'s current trading volume is 1.74M, compared to an average daily volume of 2.34M.
During the past year, Amgen(AMGN) stock moved between $269.77 at its lowest and $447.03 at its peak.
During the past year, Amgen(AMGN) stock moved between $269.77 at its lowest and $447.03 at its peak.
AMGN News
Key Points Amgen is a diversified pharmaceutical giant with high net margins. It reported nearly $8.1 billion in free cash flow for fiscal 2025. Axsome Therap...
Schwab US Dividend Equity ETF ( $SCHD ) has fallen by 0.88% in the past week. It has experienced a 5-day net inflow of $640.6 million. This is due, in part, to...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen’s latest psoriasis study update spotlights apremilast (AMG 407) for kids and teens....
Analyst ratings
47%
of 36 ratingsMore AMGN News
Amgen (NasdaqGS:AMGN) and AstraZeneca reported positive Phase III results for Tezspire in eosinophilic esophagitis, supporting a potential label expansion. The...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has started a new Phase 1 trial called “A Phase 1, Open-Label, Single-D...
AstraZeneca AZN and its partner Amgen AMGN jointly announced positive top-line data from the late-stage CROSSING study, which evaluated Tezspire (tezepelumab) i...
On Thursday, AstraZeneca Plc (NYSE:PLC) and Amgen Inc. (NASDAQ:AMGN) shared topline data from the Phase 3 CROSSING trial of Tezspire (tezepelumab) administered...
Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis showed that AstraZeneca (AZN) and Amgen’s (AMGN) TEZSPIR...
In August 2026, TScan Therapeutics disclosed that Amgen elected to terminate their May 2023 Research Collaboration and License Agreement focused on Crohn's dise...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.